Advertisement
Advertisement
CLDI
Calidi Biotherapeutics, Inc.
1.20
USDSponsored
+0.11
+10.09%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
1.19
-0.01
-0.83%
Calidi Biotherapeutics, Inc. Financial Snapshot
| Market Cap | 3.08M |
| Beta | 1.32 |
| Earnings Per Share (EPS) | -54.30 |
| Price-to-Book (P/B) Ratio | 0.74 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 29.62% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -368.29% |
| Current Ratio | 1.68% |
| Free Cash Flow | -8.51M |
